Per the multiple posts here and on various blogs regarding BTD, Brigatinib could be authorized for sale by FDA well before 2-3 years, and given previous examples it could be as early as tomorrow. July is the projected approval date if you use mean BTD/Market approval timing for previously approved BTD molecules. No news here.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.